NCT06868602

Brief Summary

In this study, it was aimed to observe the effect of psychoeducation, which has not yet been included among the treatment methods of sarcopenia, which affects elderly individuals both physically and psychologically and has been proven to negatively affect their quality of life, on Quality of Life, Depression and Physical Function when applied with exercise therapy. It is known that exercise programs applied in the treatment of sarcopenia, which has become a common problem in elderly individuals and is known as the trigger of most symptomatic diseases, have positive effects. However, no psychoeducation program has been applied to date in the treatment of sarcopenia, which is thought to trigger psychological factors as well as physical factors. In this direction, it is aimed to contribute to sarcopenia treatment and indirectly to geriatric rehabilitation programs according to the results we will obtain in sarcopenic individuals with the psychoeducation program, which we think is lacking. In addition to all these, sarcopenia, which is a treatable diagnosis and one of the biggest obstacles to the independent life of elderly individuals, is thought to be a preventable condition with preventive rehabilitation programs. Researchers believe that preventive rehabilitation programs will positively affect the amount spent on elderly care services, which constitute a large portion of our country's health expenses, and Researchers aim to support these issues with the results they will obtain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

14 days

First QC Date

February 25, 2025

Last Update Submit

March 7, 2025

Conditions

Keywords

sarcopeniaexercisepsychoeducation

Outcome Measures

Primary Outcomes (7)

  • TUG test

    A chair and a stopwatch are required for the test, which evaluates the risk of falls and mobility in the elderly. The test is performed with the shoes the individual always uses. A 3-meter area is determined in front of the chair. The individual is asked to get up from the chair, walk this distance, and sit down again.

    Before treatment

  • SF-12 Test

    It is an abbreviated form for assessing quality of life. This form, developed by Ware et al. (1995), is not specific to any age or type of disease, but is a scale that assesses the person's quality of life over the last four weeks. SF-12; It includes the sub-elements of physical functioning, physical role, pain, general health, emotional role, mental health, social functioning and vitality and consists of 12 questions.

    Before treatment

  • GDS

    This scale was developed by Yesavage et al. (1983). The Turkish adaptation of the scale was made by Ertan et al. The scale is self-reporting, aimed at the elderly, easy to answer and consists of 30 questions. A higher score indicates a higher level of depression.

    Before treatment

  • Bioelectrical impedance analysis (BIA)

    Bioelectrical impedance analysis (BIA) measurement; It is a non-invasive measurement. It takes advantage of the different resistance of different tissues in the body to currents. A weak electric current is directed to the body and the impedance is measured. It is used to estimate body composition parameters such as total body water and fat-free mass.

    Before treatment

  • SARC-F

    SARC-F; It allows health professionals to quickly and easily assess the risk of sarcopenia in primary health care. It asks 5 questions about "strength, assistance while walking, getting up from a chair, climbing stairs and falling". The SARC-F score range is from 0 to 10, with a score range of 0-3 representing a healthy condition and a score range of 4 and above representing a symptomatic condition.

    Before treatment

  • Standardized Mini Mental Test (SMMT)

    Mini Mental Test developed by Folstein et al. (1975) allows for cognitive assessment in a short time. In this respect, SMMT is a short, easy-to-apply and standardized test used to determine the cognitive level globally.

    Before treatment , pre test only

  • Handgrip strength assessment

    During the assessment, the individual is seated upright on a chair without surface support for the arm being assessed. The arm to be measured is positioned in a free position, with the knee angle and elbow angle at 90 degrees. The subject is asked to squeeze the dynamometer with their fingers as hard and tight as possible. The measurements are repeated 3 times, with 10 seconds between them and each measurement being no less than 5 seconds, and any interventions that may affect the measurements during the assessment are avoided.

    Before treatment

Secondary Outcomes (5)

  • TUG test

    Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)

  • SF-12 Test

    Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)

  • GDS

    Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)

  • Bioelectrical impedance analysis (BIA)

    Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)

  • Handgrip strength assessment

    Within a week of the end of treatment (within 1 week of the completion of the 8-week treatment)

Study Arms (3)

control

NO INTERVENTION

This group will be informed about exercise and psychoeducation only once after the sessions are completed.

exercise

ACTIVE COMPARATOR

Physical exercise will be performed for 45 minutes twice a week for eight weeks.

Other: Exercise

exercise and psychoeducation

ACTIVE COMPARATOR

A 45-minute exercise program twice a week and a 45-minute psychoeducation program once a week will be implemented for 8 weeks.

Other: psychoeducationOther: Exercise

Interventions

Although the literature investigating the effectiveness of exercise programs on quality of life, physical function and depression in sarcopenic individuals is extensive, no studies have been found in which psychoeducation programs are applied to sarcopenic individuals and their effectiveness is investigated. In this planned study,Researchers aim to observe what kind of results will emerge and in what direction the psychoeducation program will shape the treatment by applying both exercise and psychoeducation programs to sarcopenic individuals.

Also known as: exercise
exercise and psychoeducation

Although the literature investigating the effectiveness of exercise programs on quality of life, physical function and depression in sarcopenic individuals is extensive, no studies have been found in which psychoeducation programs are applied to sarcopenic individuals and their effectiveness is investigated. In this planned study, Researchers aim to observe what kind of results will emerge and in what direction the psychoeducation program will shape the treatment by applying both exercise and psychoeducation programs to sarcopenic individuals.

exerciseexercise and psychoeducation

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 60 and over who have signed a consent form and agreed to volunteer for the study.
  • Individuals classified as sarcopenic according to the criteria of the European Working Group on Sarcopenia (EWGSOP2).
  • Individuals who scored 24 points or higher on the Standardized Mini Mental Test.

You may not qualify if:

  • Individuals with neurological disease,
  • Individuals with advanced kidney disease,
  • Individuals with pacemakers,
  • Individuals with advanced vision and hearing problems,
  • Individuals with advanced dementia,
  • Individuals with orthopedic disabilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayıs University

Samsun, 55400, Turkey (Türkiye)

Location

MeSH Terms

Conditions

SarcopeniaMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Esra Erdoğan

    Ondokuz Mayıs University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In this study, a pre-test-post-test randomized control and placebo group quasi-experimental research design will be used. In order to determine whether elderly individuals who voluntarily accept to participate in the study are sarcopenic according to the definitive diagnostic criteria of the European Working Group (EWGSOP2), muscle strength assessment (with a handheld dynamometer), muscle mass assessment (with a Bioelectrical Impedance (BIA) device) and Physical performance assessment (with the Timed Up and Go test and SARC-F test) will be performed; then, the SMMT will be applied to sarcopenic individuals and those who score 24 points and above and meet the inclusion criteria will be included in the study. Elderly individuals who meet the inclusion criteria will be assigned to the group where exercise will be performed, the group where exercise and psychoeducation will be done together, and the control group.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical physiotherapist

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 11, 2025

Study Start

June 1, 2024

Primary Completion

June 15, 2024

Study Completion

September 28, 2024

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

All IPD collected

Locations